LOR.TO Stock News Lorus Therapeutics Inc. (LOR.TO) 0.47 08/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lorus Therapeutics Inc. (LOR.TO) 0.47 $LOR.TO

Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers
CNW Group - Mon Jul 28, 6:00AM CDT
Lorus Therapeutics Inc. (TSX: LOR) today announced that the Food and Drug Administration (FDA) completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.

Lorus Therapeutics Reports Results for the Fourth Quarter and Full Year Ended May 31, 2014
CNW Group - Tue Jul 15, 3:46PM CDT
Lorus Therapeutics Inc. (TSX: LOR) today reported financial results for the year and three months ended May 31, 2014 and provided an overview of fiscal 2014 highlights and recent accomplishments. Unless specified otherwise, all amounts are in Canadian dollars.

Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing
PR Newswire - Tue Jul 15, 3:28PM CDT
Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the"Company" announces that its shareholders will be asked to approve (i) a change of the corporate name to "Aptose Biosciences Inc." as part of its comprehensive rebranding efforts; and (ii) a consolidation of the common shares of the Company at a ratio within the range of one (1) common share for each five (5) to fifteen (15) common shares (the"Share Consolidation" at its annual and special meeting of shareholders (the "Meeting". The Meeting will be held at 10:00 a.m., Toronto time, on August 19, 2014 at the office of McCarthy Tétrault LLP located at Suite 5300, Toronto-Dominion Bank Tower, 66 Wellington Street West, Toronto, Ontario M5K 1E6.

Lorus Therapeutics To Host Fourth Quarter and Year End 2014 Financial Results Conference Call and Webcast
CNW Group - Thu Jul 10, 6:00AM CDT
Lorus Therapeutics Inc. (TSX: LOR) today announced that the Company will release its fourth quarter and year end 2014 financial results on Tuesday, July 15, 2014 after the close of the market. The company intends to host a conference call on the same day at 5:00 p.m. EDT to discuss the financial results.

Lorus Therapeutics to Present at the 9th JMP Securities Healthcare Conference
CNW Group - Thu Jun 19, 6:00AM CDT
Lorus Therapeutics Inc. (TSX: LOR) today announced that William G. Rice, Ph.D., Chairman and Chief Executive Officer, will present at the 2014 9th JMP Securities Healthcare Conference on Wednesday, June 25, 2014, at 12:00 p.m. ET at the Westin New York Grand Central in New York City. Dr. Rice will provide a corporate overview of the Company's recent financing activities and strategic direction including plans to develop Lorus' lead clinical agent LOR-253 for acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and other hematologic malignancies.

Lorus Therapeutics to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference
PR Newswire - Mon Jun 16, 6:00AM CDT
Lorus Therapeutics Inc. (TSX: LOR) today announced that William G. Rice, Ph.D., Chairman and Chief Executive Officer, will present at the 2014 Bloom Burton & Co. Healthcare Investor Conference on Wednesday, June 18, 2014, at 10:30 a.m. ET at the Toronto Board of Trade in Toronto. Dr. Rice will provide a corporate overview of the Company's strategic direction including plans to develop Lorus' lead clinical agent LOR-253 for acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and other hematologic malignancies.

Lorus Therapeutics Provides Update on Warrants
PR Newswire - Tue Jun 10, 6:30AM CDT
Lorus Therapeutics Inc. (TSX: LOR) (Lorus" is pleased to announce that 18.5 million common share purchase warrants and 1.2 million broker warrants expiring on June8, 2014 and originally issued in connection with a financing completed in June2012, have been exercised recently, raising approximately $8.7million in net proceeds since mid-April. The proceeds will be used for working capital and general corporate purposes.

Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Marketwire - Thu Mar 27, 4:01PM CDT
Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Company" is pleased to announce that all of the nominees listed in the management proxy circular dated February 24, 2014 were elected as directors of Lorus at the Company's annual and special meeting of shareholders held today in Toronto (the "Meeting".

IIROC Trade Resumption - LOR (all issues)
CNW Group - Thu Mar 27, 10:15AM CDT
Trading resumes in:

IIROC Trading Halt - LOR
CNW Group - Wed Mar 26, 2:38PM CDT
The following issues have been halted by IIROC:

Lorus Therapeutics Announces the Departure of Its President and Chief Operating Officer
Marketwire - Tue Mar 18, 7:24PM CDT
Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Company" announced that Dr. Aiping Young is leaving her position as President and Chief Operating Officer of Lorus, effective today. William G. Rice, Ph.D., Chairman of the Board and Chief Executive Officer of the Company, and the other members of the Company's Board of Directors, on behalf of Lorus, thank Dr. Young for her years of service to the Company and wish her well in her future endeavors. Dr. Young's responsibilities will be assumed by other members of senior management.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 43

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 49

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 87

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 12

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 34

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 55

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 54

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 31

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Challenge: Investors Pursue Justice Against TLX

Updated Category News Views 164

Opportunity for Investors in Telix Pharmaceuticals Ltd. Attention, investors! A significant event has unfolded for those who have purchased securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). The Rosen Law Firm, well-known for representing investors' rights, has initiated a class action lawsuit on behalf of these investors. This development presents a chance for you...

Continue Reading
Turvo and SMC3 Forge Alliance to Enhance Freight Efficiency

Updated Category News Views 158

Strategic Partnership Between Turvo and SMC3 Industry leaders are joining forces to enhance freight management solutions, facilitated by insights from a global logistics company. Turvo, known for its collaborative application tailored for the supply chain, has announced an integration partnership with SMC3, a respected provider of less-than-truckload (LTL) freight...

Continue Reading
Fnac Darty Takes Major Steps in Unieuro Acquisition Process

Updated Category News Views 148

Fnac Darty Makes Progress in Unieuro Acquisition Fnac Darty has recently announced significant developments regarding its acquisition of Unieuro. The authorization to officially notify this transaction was granted by the European Commission, following a pre-notification phase that lasted several months. This is an exciting development for shareholders and has set the...

Continue Reading
LOGISTEC Appoints Cleidy Liborio Fernandes as CCO for Growth

Updated Category News Views 202

CLEIDY LIBORIO FERNANDES JOINS LOGISTEC AS CHIEF COMMERCIAL OFFICER LOGISTEC, a prominent provider of marine and environmental services in North America, is delighted to announce the appointment of Cleidy Liborio Fernandes as the new Chief Commercial Officer. Cleidy's extensive background in international business and strategic development is expected to spearhead the...

Continue Reading
IMUNON Inc's Latest Developments Drive Stock Surge Today

Updated Category News Views 233

IMUNON Inc's Stock Surge Explained Shares of IMUNON Inc (NASDAQ: IMNN) are seeing a remarkable uptick in trading this Wednesday. The excitement is largely due to the company achieving a significant clinical milestone for its lead drug candidate, IMNN-001. This news has generated substantial interest among investors and highlights IMUNON's progress in the pharmaceutical...

Continue Reading